inducible by all-trans-retinoic acid (at-RA) as expected and also responded to PB. The latter can be attributed to nuclear accumulation of CAR after PB exposure. Exogenous CAR increased both the EDVDO DQG 3%LQGXFHG UHVSRQVH RI 5$5(×2-tk but reduced PBRU-dependent PB response.
INTRODUCTION
Hepatic cytochrome P450s (CYPs) 1 play a critical role in the metabolism of hydrophobic xenobiotics and many CYPs are selectively inducible by xenobiotic compounds. Recently progress has been made toward understanding the molecular mechanisms underlying phenobarbital (PB) inducibility of the homologous rat CYP2B2 (and CYP2B1) and mouse Cyp2b10 genes (1) (2) (3) (4) (5) (6) (7) (8) (9) [reviewed in (10) (11) (12) (13) ] and of the chicken CYP2H1 gene (14) . We identified a 163-bp Sau3AI fragment at coordinates -2317/-2155 in the CYP2B2 5'-flank that confers PB inducibility on the heterologous tk promoter and has the properties of a transcriptional enhancer when cat reporter constructs are transfected into primary rat hepatocytes (1) . The homologous region of the 5'-flank of the PB-inducible mouse Cyp2b10 gene was found to contain a 162-bp segment 92% identical to the rat CYP2B2 163-bp fragment (there is a 1-bp deletion in the mouse sequence with respect to the rat, see Fig. 1A ) that also possesses the properties of a transcriptional enhancer and confers PB inducibility on the heterologous tk promoter in primary mouse hepatocytes (3) . Further analysis of the rat 163-bp Sau3AI fragment led us to conclude that it is a multicomponent enhancer constituting a PB response unit or PBRU (4) . The localization of the PBRU at coordinates -2317/-2155 in the CYP2B2 5'-flank is in agreement with results obtained from studies with transgenic mice where the sequences necessary for PB responsiveness were localized between CYP2B2 coordinates -2500 and -1700 (15).
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The rat CYP2B2 PBRU contains, among other putative transcription factor recognition sites, a putative glucocorticoid response element (GRE), a nuclear factor 1 (NF1) site, and an accessory site (AF1) (4) (Fig. 1A) . It also contains two direct repeats separated by 4 bp (DR-4) of the nuclear receptor consensus hexamer half-site motif AGGTCA. These DR-4 sites, NR1 and NR2, which flank the NF1 site, were recognized as putative nuclear receptor binding sites by Negishi and coworkers in the homologous mouse Cyp2b10 fragment (8) . Furthermore, Negishi and coworkers have defined a 51-bp PB responsive enhancer module (PBREM) within the mouse Cyp2b10 PBRU sequence. The PBREM is limited to the NR1-NF1-NR2 elements (Fig. 1A ) and confers full PB responsiveness on the heterologous tk promoter (8) . Except for a single bp difference in the NR2 spacer, the Cyp2b10 PBREM is identical to the corresponding rat CYP2B1 and CYP2B2 sequences (Fig. 1A ). Negishi and coworkers (7) also reported that mutation of any one of the four NR1 or NR2
hexamer half-sites in the mouse 51-bp PBREM (i.e., NR1A, NR1B, NR2A or NR2B) reduced but did not abolish PB responsiveness conferred on the heterologous tk promoter, whereas mutation of one half-site in both NR1 and NR2 completely abolished such activity.
In addition Negishi and coworkers (7, 9) have shown that there is a PB-dependent nuclear accumulation of the constitutive androstane receptor (CAR) in mouse liver. CAR, in the form of a heterodimer with the retinoid X receptor (RXR) binds to the UHWLQRLF DFLG UHVSRQVH HOHPHQW
(5$5( DQG ZLWK ORZHU DIILQLW\ WR WKH 15 DQG 15 VLWHV RI WKH 3%5(0 DQG
activates transcription of reporter genes driven by these enhancers in cultured cell lines (7, 9, 18) .
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because PB itself, at a concentration (1 mM) that induces both nuclear localization and Cyp2b10 expression in primary mouse hepatocytes (9) , fails to display agonist activity with respect to CAR (18, 19) . Furthermore, PB at 0.5 mM in fact exhibits antagonist activity with respect to human and mouse CAR (19. In any event, ligand-independent transcriptional activation by CAR-RXR heterodimers is thought to account for the PB-induced expression of CYP2B genes (7, 9) .
Although the postulated positive role for CAR in the PB-induced expression of CYP2B genes via the 51-bp PBREM (7, 9) has gained wide acceptance (12, 18, 21) , there are a number of puzzling anomalies in the results reported to this point. One such anomaly is that sequences outside the 51-bp PBREM appear to be important for conferring PB responsiveness. In our previous work (4), deletion and point mutants of the 163-bp CYP2B2 PBRU were subcloned into the EcoRV site of the non-PB responsive Ev construct which contains 1681 bp of the CYP2B2 5'-flanking region cloned upstream of a cat reporter (1). Mutation of the putative GRE 5' of the PBREM substantially reduces PB responsiveness conferred by the rat PBRU in this sequence context (4). Furthermore, Honkakoski and Negishi (3) reported that sequences they referred to as pB' on the 5' side of the 51-bp PBREM contribute to the activity of the Cyp2b10 PB-dependent enhancer: deletion of pB'
(which removes the putative GRE) reduces but does not abolish PB-dependent induction. In addition, deletion analysis of the CYP2B2 PBRU using transfection into primary rat hepatocytes (4) or in situ injection into rat liver (6) led to the conclusion that a central region (consisting in whole or in part of the PBREM) acts together with upstream or downstream elements within the 163-bp 6 2257/-2188) contained the rat equivalent of an NR2B-mutated version (GTGTCA → CCGTCA) of the 51-bp PBREM. Hence it might have been expected to retain partial activity, but it was completely inactive in conferring PB responsiveness in our system (4) (note that AF1 and NR2B
overlap, see Fig. 1A ). Finally, and even more striking, the 5' ends of two deletions, -2317/-2207 and -2257/-2207, are different, but both possess NR1, and their identical 3' ends are within the NF1 site such that they both lack NR2 (Fig. 1A) . According to a model wherein the PBREM contains all the sequences necessary for PB responsiveness, they both should be partially active, or perhaps both completely inactive, but in any case they should be identical. However, -2317/-2207 was partially active whereas -2257/-2207 was completely inactive.
It seemed possible that the sequence contexts used for the reported studies by transfection into primary hepatocytes of the mouse Cyp2b10 PBREM (placed directly upstream of the heterologous tk promoter) versus the rat CYP2B2 PBRU (placed at -1681 in the context of the CYP2B2 5' flank) might explain some of these anomalies. We report here the results of a series of experiments in which the PBRU and the PBREM were tested in primary rat hepatocytes for their capacity to confer PB responsiveness when placed in the sequence contexts mentioned above as well as directly upstream of the basal rat CYP2B2 promoter and in the natural context of the rat CYP2B2 5' flank (Fig. 1B) . In addition we report on the effects of a series of mutations on PB responsiveness conferred by the rat CYP2B2 PBRU in its natural context, as well as the effect of exogenous CAR on PB responsiveness. The results are compatible with a model in which CAR acts negatively on PB responsiveness mediated by the rat CYP2B2 PBRU. ITS (insulin, transferrin and selenium) was from Sigma, Vitrogen 100 was from Collagen Canada, collagenase Type IV was from Sigma, Percoll was from Amersham Pharmacia Biotech, and dexamethasone phosphate was from Sabex. Petri dishes (60 mm, Permanox) were from NUNC.
EXPERIMENTAL PROCEDURES
Male Sprague-Dawley rats (150-180 g) were from Charles River Canada.
Isolation and Culture of Primary Hepatocytes, Transfection, PB Treatment and Luciferase
Assays-The methods for hepatocyte isolation and culture in serum-free medium, essentially those of Waxman et al. (22) , as well as those for liposome-mediated transfection (23) were as described (1) except that for hepatocyte culture Matrigel was omitted and dexamethasone was present at 10 nM. Plasmids were purified using a plasmid purification kit (Qiagen). Unless otherwise noted 4 × 10 6 cells were plated in serum-free modified Chee's medium (22) mutants. Cleavage of the X construct with BglII followed by religation generated the enhancerless X construct. The PBREM-X construct was obtained by subcloning the PBREM into the BglII site of the enhancerless X construct. PBREM mutants were generated in the PBREM-X construct. The -120 constructs were obtained by first creating a BglII restriction site at -122 of the CYP2B2 5' flank by site-directed mutagenesis of the pBSCAT-Ev construct (1) using -136
GGTGTCCTTGCCAAgATCTATGGTGTGGGT as the upper strand mutant oligo (the mutated base is shown in lower case). The basal CYP2B2 promoter was then subcloned as a BglII-HindIII fragment into pGL3 and the PBRU and the PBREM were subsequently subcloned upstream of this.
The PCR-based QuikChange system (Stratagene) system was used for site-directed mutagenesis. The presence of the expected mutated bases and no others was confirmed by sequencing of the PBRU or PBREM within the reporter plasmid prior to use. With the exception of the GRE mutation, the mutations used for functional analysis of the PBRU or PBREM (Table 1) were generated in the reporter plasmid in the natural sequence context. The GRE mutation was that of Stoltz et al. (4) . It was moved with the PBRU as a Sau3AI fragment from its original context (4) and subcloned into the BglII site of the X construct. 
RESULTS

The PBRU and PBREM are not Equivalent When Tested in the Natural Sequence Context-
The mouse Cyp2b10 and rat CYP2B2 PBREMs differ by a single nucleotide in the NR2 spacer ( Fig.1A ) and conferred identical PB responses when tested in the tk and natural sequence contexts (data not shown). In accord with the conclusions of Honkakoski et al. (8) , the mouse Cyp2b10 PBRU and rat CYP2B2 PBREM gave essentially equivalent PB responses when tested in the tk sequence context ( Fig. 2A ). In the homologous -120 sequence context, the rat CYP2B2 PBRU gave about a two-fold higher PB response than the rat PBREM (Fig. 2C ). In the Ev sequence context, that is when the rat PBRU or PBREM were placed directly upstream of EcoRV site at -1681 in the CYP2B2 5' flank, the PBREM conferred a strikingly weaker PB response than the PBRU (Fig. 2B ).
Indeed, in the Ev sequence context, the PBREM gave such a low fold PB induction as to be virtually a null mutant with respect to PB responsiveness. When tested in the natural sequence context of the X construct, the difference between the PBRU and PBREM was less dramatic than in the Ev context, but still striking, as the PBREM conferred about a four-fold lower response ( The rat PBRU conferred a slightly higher PB response than the mouse PBRU in tk context ( Fig. 2A ). In the natural sequence context the fold PB induction was very similar for both PBRUs, except that both the basal and induced levels were slightly elevated for the mouse form (data not shown). These subtle differences in PB response conferred by the rat CYP2B2 PBRU as opposed to the mouse PBRU presumably reflect one or more of the 14 sequence differences between them (Fig.
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The basal level of luciferase activity is higher with the tk than with the CYP2B2 promoter (data not shown). For this reason, the PBRU-dependent PB response (fold-PB induction) for the rat form is lower in the tk context, typically less than 20-fold ( Fig. 2 and data not shown) than with the CYP2B2 promoter where it varies with hepatocyte preparation, typically between 25-and 100-fold ( Fig. 2 and data not shown).
Mutational Inactivation of Any NR1 or NR2 Half-Site Abolishes PB Responsiveness
Conferred by the PBREM in the Natural Sequence Context-We observed previously that mutation of the putative GRE substantially reduced PB responsiveness conferred by the rat PBRU in the Ev sequence context (4) and this mutation has a similar effect in the natural sequence context (Fig. 3A) .
The putative GRE site overlaps the 5' end of the PBREM, but the mutation (GGCACA→GGCGTG)
is outside the PBREM ( (7) and for the identical NR1B mutation (24) and another NR1B mutation (4) of the rat PBRU in the Ev context. Furthermore, double half-site mutations of both NR1 and NR2
(NR1A-NR2A and NR1A-NR2B) abolished PB responsiveness conferred by the PBRU in the 12 natural sequence context (Fig. 3B) , as do double half-site mutations of the mouse PBREM in the tk sequence context (7) . However, in the natural sequence context PB responsiveness conferred by the rat PBREM was completely abolished by mutation of any one of the four NR1 or NR2 half-sites (Figs. 3A and 3B ). This provides a clear demonstration that sequences outside the PBREM are important for conferring PB responsiveness in the natural sequence context since these same halfsite mutations diminish but do not abolish PB responsiveness when present in the complete PBRU.
Mutation of the ER-7A Half-Site Also Reduces the PB Responsiveness Conferred by the
PBRU-In addition to the putative transcription factor-recognition sites in and around the PBREM, the rat CYP2B2 PBRU also contains two other AGGTCA sequences in an everted repeat (ER)
arrangement with a 7-bp spacing (ER-7A and ER-7B, coordinates -2282 to -2264) (Fig. 1A ). This region is protected from DNase I digestion by proteins present in nuclear extracts of rat liver (4) and hence has the potential to contribute to PBRU-dependent PB responsiveness. Mutation of the ER-7A half-site reduced but did not abolish PB responsiveness. The residual activity was similar to that of the GRE mutant and of NR1 and NR2 half-site mutants (Fig. 3A ). This provides a further demonstration that sequences outside the PBREM are necessary for maximal PB responsiveness.
The level of PB responsiveness conferred by the PBREM in the natural sequence context is similar to or lower than that of NR1 or NR2 half-site mutants and generally lower than that of the ER-7A mutant or of the mutant affected in the putative GRE ( responsiveness whereas when it replaces NR2 it is fully functional. The non-equivalence of NR1
and NR2 in conferring PBRU-dependent PB responsiveness was confirmed by converting NR1 to NR2 (NR1→NR2), which had the same effect as inactivating either NR1 half-site, and by converting NR2 to NR1 (NR2→NR1), which increased PB responsiveness by nearly 2-fold ( Fig.   3D and data not shown). Taken together these results appear to be incompatible with a positive role for CAR in PB-dependent activation via the NR1 site. Furthermore they indicate that the region surrounding NR1 plays a key role in conferring PB responsiveness.
Exogenous CAR and PB both Activate 5$5( EXW &$5 ,QKLELWV 3%58'HSHQGHQW 3%
Responsiveness-We used a luc reporter construct containing two copies of responsiveness is not a consequence of some non-specific inhibition (such as the creation of an inaccessible chromatin conformation) and appears to be incompatible with a positive role for CAR in PB-dependent activation via the NR1 site of the PBRU.
CAR Inhibition of PB Responsiveness Conferred by PBRU-5$5( 0XWDQWV²Exogenous
CAR inhibits the residual PB responsiveness conferred by NR1 or NR2 half-site mutations tested in the natural sequence context. This inhibition is modest and comparable to that observed for the wild type PBRU tested in the tk sequence context (data not shown). When tested in the natural sequence context, the PB responsiveness conferred by the PBRU carrying the NR1→5$5( PXWDWLRQ ZDV also subject to modest inhibition by exogenous CAR (Fig. 5B) . However, the PB responsiveness 16 conferred by the PBRU carrying the NR2→5$5( PXWDWLRQ ZDV LI DQ\WKLQJ PRUH VHQVLWLYH WR inhibition by exogenous CAR than was that conferred by the wild type PBRU (Fig. 5B) .
Sequestration of Endogenous RXR Does Not Account for Inhibition of PB Responsiveness by
Exogenous CAR-One possible mechanism to account for the inhibition of PB responsiveness by exogenous CAR would be sequestration of endogenous RXR. To test this possibility, the PBRUcontaining X reporter construct was cotransfected with 10 and 100 ng of the CAR expression vector into hepatocytes with and without equivalent amounts of a human RXRα expression vector (Fig. 6 ). 
PB and CAR Reduce Luciferase Levels With Enhancerless Constucts in All Sequence
Contexts-As expected, the enhancerless CYP2B2 constructs corresponding to the natural sequence context (the X construct), the Ev context, and the -120 context did not respond to PB, and indeed there was a slight reduction in basal luciferase activity in the presence of PB (Fig. 7) . A similar reduction was observed in the presence of exogenous CAR and this reduction was amplified in the presence of PB such that the overall reduction of basal luciferase in the presence of both PB and CAR was approximately two-fold (Fig. 7) . Similar results were obtained for the enhancerless tk construct with exogenous CAR and for the enhancerless X construct with exogenous CAR and RXR (data not shown). The basal level for the enhancerless -120 construct was about three-fold higher than that for the enhancerless Ev and X constructs, suggesting that negative elements are present in the CYP2B2 5' flank. An intriguing possibility to account for the concerted effect of PB and CAR in reducing basal luciferase is that it is due to nuclear accumulation of CAR. According to this scenario, PB would reduce basal luciferase levels by provoking nuclear accumulation of endogenous and exogenous CAR. In any case the enhancer-independent suppressive effect of CAR, and of CAR plus PB, is presumably operative in enhancer-containing constructs as well, although the amplitude of this effect is insufficient to explain the dramatic inhibition by exogenous CAR of PBRU-dependent PB responsiveness in the natural sequence context (compare Fig. 7 with Figs. 5B and 6).
Transcription of the peroxisomal acyl-CoA oxidase gene is activated by binding of peroxisome SUROLIHUDWRUDFWLYDWHG UHFHSWRU . PPARα) as a PPARα-RXR heterodimer to an upstream peroxisome proliferator response element (PPRE). Exogenous CAR has recently been reported to inhibit ligand-dependent and ligand-independent transcriptional activation of the acylCoA oxidase PPRE mediated by PPARα-RXR heterodimers (25) . This inhibitory effect of exogenous CAR may be analogous to that observed here with enhancerless constructs, given that CAR-RXR heterodimers do not bind to the acyl-CoA oxidase PPRE (25) .
DISCUSSION
In accord with our earlier conclusions (1,4), the results of the present study demonstrate that the CYP2B2 PBRU is a complex multicomponent enhancer conferring PB responsiveness on homologous and heterologous promoters. It consists of at least four sequence elements (ER-7, GRE, NR1 and NR2), all of which seem to be essential for conferring maximal PB responsiveness. With the highly responsive luc reporter construct used here, the PBRU is the only detectable PBdependent enhancer within the first 2.5 kb of the CYP2B2 5' flank capable of conferring PB responsiveness. This is consistent with earlier results obtained with cat constructs indicating that no other PB-dependent enhancers are present within the first 4.5 kb of the CYP2B2 5' flank (1).
Furthermore, the fold PB induction conferred by the PBRU with the luc reporter system used here is comparable to or even exceeds that observed in vivo for the CYP2B2 protein (26) . Thus the PBRU appears to be sufficient to account for in vivo PB responsiveness of the CYP2B2 gene and probably for the CYP2B1 gene as well.
A 51-bp subfragment of the mouse Cyp2b10 PBRU, the PBREM, confers full PB responsiveness on the heterologous tk promoter in mouse (8) hepatocytes. With the rat system, the PBREM also confers near maximal PB responsiveness in tk context ( Fig. 2A) . However, the results presented here demonstrate that in the natural CYP2B2 sequence context, the 51-bp PBREM does not confer full PB responsiveness, indicating that PBRU sequences outside the PBREM contribute to PB-dependent enhancer activity. Mutational analysis of the PBRU has identified two such sequence elements, a putative GRE that overlaps the 5' end of the PBREM (4), as well as an upstream ER-7 element (Fig. 3A) . The precise role of the putative GRE and the ER-7 elements in conferring PB responsiveness remains to be determined. A striking confirmation of the presence of sequences outside the PBREM essential for full responsiveness is obtained by comparing, in the 19 natural and tk sequence context, the effects on PB responsiveness of NR1 or NR2 half-site mutations in the PBRU and PBREM. Whereas in the tk context, NR1 and NR2 half-site mutations reduce but do not abolish PB responsiveness conferred by the PBREM (7), in the natural sequence context such mutations completely eliminate PB responsiveness (Figs. 3A and 3B) . The residual activity retained in the tk context by the PBREM mutated in a NR1 or NR2 half-site may result from the enhancer being placed directly upstream of the promoter or may reflect sequence elements provided by the tk promoter itself. We have not investigated the question of which proteins may be responsible for the increased PB response conferred by the PBRU as opposed to the PBREM.
However, there is no particular reason to believe that they should be CAR-RXR heterodimers, given that maximal responsiveness of other complex multicomponent enhancers typically requires interactions between several different transcription factors (27) . Notably, up to five different factors activate the glucocorticoid response unit of the phosphoenolpyruvate carboxykinase gene (28). The inhibition by exogenous CAR of PBRU-dependent PB responsiveness conferred by the PBRU appears at first glance to be counterintuitive, given that PB is known to provoke an accumulation of CAR in the nucleus of hepatocytes (7,9). However, the physiological level of endogenous CAR is apparently too low to provoke inhibition of PBRU-dependent PB responsiveness. This interpretation is supported by the observation that (in the absence of exogenous RXR) low levels of exogenous CAR (1 or 10 ng of CAR expression vector/transfection) were without detectable inhibitory effect on PB responsiveness (Fig. 6 ).
It is well established that in cell lines CAR/RXR heterodimers activate transcription of reporter constructs in which various orphan nuclear receptor response elements are placed directly The results of our experiments in which exogenous CAR inhibited PBRU-dependent PB responsiveness not only fail to support the postulated positive role for CAR in PB induction of CYP2B genes, they suggest that in primary hepatocytes CAR if anything acts to inhibit PB responsiveness. However, one interpretation that might be compatible with a positive role for CAR would be that in hepatocytes PB-type inducers normally cause a redistribution of CAR from the cytoplasm to the nucleus (9) and that this redistribution is accompanied by an okadaic acid-sensitive process (9,32) which, since okadaic acid is a protein phosphatase inhibitor (33), could involve an as yet undefined and therefore hypothetical activation of CAR via dephosphorylation. If exogenous CAR reached the nucleus in an "inactive" form, it might interfere with transcriptional activation by endogenous CAR. This scenario seems unlikely however, given that exogenous CAR is competent to activate 5$5(GHSHQGHQWWUDQVFULSWLRQLQXQWUHDWHGDQGLQ3%WUHDWHGKHSDWRF\WHV)LJA).
Furthermore, as we have seen, the results of the mutational analyses wherein NR1 or NR2, or both, were converted into 5$5(DUHYHU\GLIILFXOWWRUHFRQFLOHZLWKDSRVLWLYHUROHIRU&$5LQ
activating PBRU-dependent PB responsiveness via the NR1 site. genes is maintained.
In any case, it is worth recalling that our results from reporter gene assays with respect to the localization and properties of the CYP2B2 PBRU have been in accord with results obtained from studies with transgenic mice (15) and from in situ injection of reporter constructs into rat liver (6).
Furthermore, we have studied the PBRU in its natural sequence context to minimize possible 23 artifacts associated with the use of heterologous promoters. In so doing we have followed the precedent set with studies of the rat PEPCK glucocorticoid response unit (28) .
In summary then, insofar as the results of the present study performed with reporter gene constructs reflect the behavior of the endogenous CYP2B genes in chromatin, they indicate that the molecular mechanism of PB induction of CYP2B2 via the PBRU in its natural sequence context is both different from and more complicated than that suggested by recent models (9, 12, 13) . NR1 and converted to NR2 as well, it is non-functional for conferring PB responsiveness. This suggests that at the NR1 site something other than or in addition to the binding of orphan receptor-RXR heterodimers is necessary for conferring PB responsiveness.
One of the present challenges is to identify the sequence elements, and their cognate transcription factors, that are unique to the NR1 region and that are essential for PB responsiveness.
Another challenge is to integrate the effect of sequence elements outside the NR1 region, including the ER-7 and putative GRE sites, and indeed the NF1 site, into a global model taking into account a The NR1B and NR2A oligos were also used to generate the corresponding mutations in the PBREM in the X sequence context.
b The oligos used to generate the NR1A and NR2B mutations in the PBREM in the X sequence context overlapped its 5' and 3' boundaries respectively. Bases shown in bold characters are those of the adjacent CYP2B2 5'flank. The 5' and 3' coordinates shown are those of the PBREM.
